Ruth Duncan
Publications by Year
Research Areas
Nanoparticle-Based Drug Delivery, RNA Interference and Gene Delivery, Advanced Polymer Synthesis and Characterization, Dendrimers and Hyperbranched Polymers, Cancer Treatment and Pharmacology
Most-Cited Works
- → The dawning era of polymer therapeutics(2003)3,227 cited
- → Polymer conjugates as anticancer nanomedicines(2006)1,943 cited
- → Dendrimers:(2000)1,213 cited
- → Dendrimer biocompatibility and toxicity(2005)1,140 cited
- → Nanomedicine(s) under the Microscope(2011)958 cited
- → Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors(2014)787 cited
- Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.(1999)
- → Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues(1998)461 cited
- → Drug-polymer conjugates(1992)444 cited
- → Polymer conjugates: nanosized medicines for treating cancer(2005)442 cited